This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Fuso Pharmaceutical Industries, Ltd., Hokkaido University. Active years: 2023.
Company Filing History:
1 out of 108 
1 out of 442 
Years Active: 2023
Title: Yayoi Kameda: Innovator in Mammalian Cell Expression Vectors
Introduction
Yayoi Kameda is a prominent inventor based in Hokkaido, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of mammalian cell expression vectors. Her innovative work has the potential to enhance the production of foreign gene-derived proteins, which is crucial for various applications in medicine and research.
Latest Patents
Kameda holds a patent for a "Vector including a translation-impaired dihydrofolate reductase gene cassette and ubiquitously acting chromatin opening element." This invention provides mammalian cell expression vectors that enable host cells to produce high levels of proteins derived from foreign genes. The introduction of a ubiquitously acting chromatin opening element (UCOE) into the expression vector allows for the selection of strains that can grow in hypoxanthine-thymidine (HT)-free medium, leading to increased production of the desired protein.
Career Highlights
Throughout her career, Yayoi Kameda has worked with notable organizations, including Fuso Pharmaceutical Industries, Ltd. and Hokkaido University. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Kameda has collaborated with esteemed colleagues such as Keiichi Yamamoto and Shinya Goto. These partnerships have further enriched her research and innovation efforts, leading to advancements in biotechnology.
Conclusion
Yayoi Kameda's contributions to the field of mammalian cell expression vectors exemplify her dedication to innovation and research. Her patent and collaborations highlight her role as a key figure in advancing biotechnological applications.